Bioinformatics Market

Bioinformatics Market by Product & Service (Knowledge Management Tools, Data Analysis Platforms, Structural Analysis, Functional Analysis, Services), Applications (Genomics, Proteomics), & Sector (Medical, Animal, Agricultural) – Global Forecast to 2026

Report Code: HIT 7543 Sep, 2021, by marketsandmarkets.com

[220 Pages Report] The global bioinformatics market is projected to reach USD 21.8 billion by 2026 from USD 10.7 billion in 2021, at a CAGR of 15.2% during the forecast period. Bioinformatics is the application of computer technology for the management and analysis of biological data. It includes storage, analysis, and dissemination of biological data. Bioinformatics uses computer programs for a variety of applications, including determining gene & protein functions, establishing evolutionary relationships, and predicting the three-dimensional shapes of proteins. However, high costs of bioinformatics software and services and a dearth of skilled professionals are likely to challenge market growth in the coming years.

Bioinformatics Market

To know about the assumptions considered for the study, Request for Free Sample Report

COVID-19 Impact on the Bioinformatics Market

Bioinformatics has always had huge potential when it comes to providing essential support to many areas of scientific research. The COVID-19 pandemic was a real-life test for bioinformatics. One of the major focus areas for every country during the COVID-19 pandemic has been to study and understand how to halt the progress of the virus. Next-generation sequencing is the fundamental method for investigating SARS-CoV-2 genomes, which offers basic information about the virus. Bioinformatics pipelines and biological & host-virus interaction databases are the critical tools for calculating such data and furthering comprehension of SARS-CoV-2. Thus, various studies are being undertaken to understand the genetic combination of the virus; these studies are driven by bioinformatics. In this context, the outsourcing of bioinformatics has increased during the pandemic. Due to the evolved and upgraded bioinformatics capabilities of service providers, scientists have been able to uncover numerous secrets of SARS-CoV-2, ranging from its identification to its origin (including its functioning and spread), in a short time span.

Drivers: Increasing public-private sector funding for bioinformatics

Many government bodies and private organizations across the globe are increasingly investing in the field of bioinformatics. These investments have largely resulted in data and technological advancements in bioinformatics services, which, in turn, have improved the quality of these services. For instance, in 2016, the European Molecular Biology Laboratory (EMBL), an intergovernmental organization and pioneer in bioinformatics research, received funds from the Biotechnology and Biological Sciences Research Council, British Heart Foundation, Cancer Research UK, the European Commission, European Molecular Biology Organization, the European Research Council, the Foundation of the National Institutes of Health, Bill & Melinda Gates Foundation, the Human Frontier Science Program, Innovate UK, International Policy Governance Organization, the Medical Research Council, the National Institutes of Health, National Science Foundation, Parkinson’s UK, Research Councils UK, and Wellcome, for R&D in the field of bioinformatics.

Also, many countries are investing in their national population sequencing programs to understand the link between genetics and diseases. Government organizations are sequencing the genomes of millions of citizens to advance research and help develop better ways to diagnose and treat cancer, rare diseases, and other conditions. These large sequencing projects are expected to drive the requirement of bioinformatics products and services.

Restraints: High Equipment Costs

With the advent of advanced NGS technologies, there is an increasing need for quick and accurate bioinformatics tools that can be easily operated. Most of the scientists involved in experimental research are not bioinformaticians. Therefore, the availability of user-friendly tools is vital for the use of bioinformatics platforms. Many bioinformatics tools require advanced computer expertise, mainly because they lack a suitable user-friendly interface.

Genomics instruments are also equipped with advanced features and functionalities and are thus priced at a premium, ranging between ~USD 10–20 million. As pharmaceutical companies and research laboratories require many such systems, their capital expenditure on procuring multiple genomic instruments is very high. In the case of small and medium-sized pharmaceutical companies and research laboratories, it is not feasible for them to make such high investments in multiple genomics instruments

Opportunities: Lucrative opportunities in emerging markets

Emerging markets, such as India, China, Brazil, Russia, Taiwan, and South Korea, offer high growth opportunities for the major players offering bioinformatics products and services.

The growing prominence of these emerging economies in terms of R&D and investments from global players is expected to provide a favorable outlook—as well as opportunities—for the growth of genomics, metabolomics (including chromatography, mass spectrometry, and NMR instruments), precision medicine, drug discovery, and other markets in the coming years. In addition, regulatory policies in the Asia Pacific are more adaptive and business-friendly due to fewer stringent regulations and data requirements. The increasing competition in mature markets will further compel manufacturers to focus on emerging markets.

Challenges: Patient data confidentiality concerns

The rapid advancements in next-generation sequencing (NGS) technologies have generated a large volume of biological data, and the growth of this data volume is increasing with the growing adoption of NGS. Data analysis is necessary, as a lot of information is still unexplored in genome analysis. Hence, data that remains after bioinformatics analysis carries huge importance and can be reused. The current solutions do not adequately solve the challenges of data management in bioinformatics.

North America holds the largest share in this market

North America dominated the bioinformatics market, with a share of 45.0% in 2020, followed by Europe and Asia Pacific. The large share of North America in the global bioinformatics market can be attributed to factors such as government support for genomic research, presence of leading bioinformatics providers, decreased cost of sequencing, increased awareness of bioinformatics services, and increased number of genomic research activities (and the corresponding adoption of bioinformatics) in the region are driving the growth of the bioinformatics market in North America. North America has a favorable funding scenario for research activities. This regional market is characterized by increased government initiatives for the reimbursement of genomic testing and favorable funding scenario for research activities involving the use of bioinformatics technologies.

Bioinformatics Market by Region

Key Market Players

The key players have a strong foothold in the market and offer a wide range of products & services. Some of the key players in this market are Thermo Fisher Scientific, Inc. (US), Eurofins Scientific (Luxembourg), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), and Illumina, Inc. (US), Waters Corporation (US), DNASTAR (US), NeoGenomics Laboratories (US), Perkin Elmer, Inc. (US), GENEWIZ (US) and BGI Group (China) Waters Corporation (US), DNASTAR (US), NeoGenomics Laboratories (US), Perkin Elmer, Inc. (US), GENEWIZ (US) and BGI Group (China), Fios Genomics (UK), Partek Incorporated (US), SOPHiA Genetics (Switzerland), Source BioScience (UK), and Biomax Informatics AG (Germany) among others.

Get online access to the report on the World's First Market Intelligence Cloud

  • Easy to Download Historical Data & Forecast Numbers
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
Request Sample

Scope of the Report

Report Metric

Details

Base year considered

2020

Forecast period

2021–2026

Forecast units

Value (USD Billion)

Segments covered

By Product & Services, By Application, By Sector, & By Region

Geographies covered

North America, Europe, Asia Pacific, and Rest of the World

Companies covered

The major market players include Thermo Fisher Scientific, Inc. (US), Eurofins Scientific (Luxembourg), QIAGEN N.V. (Netherlands), Agilent Technologies, Inc. (US), and Illumina, Inc. (US), Waters Corporation (US), DNASTAR (US), NeoGenomics Laboratories (US), Perkin Elmer, Inc. (US), GENEWIZ (US) and BGI Group (China) Waters Corporation (US), DNASTAR (US), NeoGenomics Laboratories (US), Perkin Elmer, Inc. (US), GENEWIZ (US) and BGI Group (China), Fios Genomics (UK), Partek Incorporated (US), SOPHiA Genetics (Switzerland), Source BioScience (UK), and Biomax Informatics AG (Germany) among others (Total 25 companies)

By Product & Services

  • Knowledge Management Tools
  • Bioinformatics Platforms
  • Bioinformatics Services

By Application

  • Genomics
  • Chemoinformatics & Drug Design
  • Proteomics
  • Transcriptomics
  • Metabolomics
  • Other Applications

By Sector

  • Medical Biotechnology
  • Animal Biotechnology
  • Plant Biotechnology
  • Environmental Biotechnology
  • Forensic Biotechnology
  • Other Sectors

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • RoE
  • Asia
    • Japan
    • China
    • India
    • RoAPAC
  • Rest of the World

Recent Developments

  • In March 2021, Agilent Technology, Inc. launched SureSelect for human exome analysis.
  • In January 2021, BGI and the Ministry of Health of Brunei expanded their partnership to carry out extensive cooperation in public health emergency response and public health testing screening and diagnostic services, including reproductive health, personalized drug guidance, early cancer screening, and detection of unknown pathogens by using BGI’s cutting-edge sequencing technology.
  • In January 2020, Charles River Laboratories, Inc. entered into a partnership with Fios Genomics to gain access to the expertise of Fios Genomics in the field of bioinformatics, statistics, and biology.
  • In December 2020, Eurofins Scientific launched optimized and cost-effective SARS-CoV-2 NGS services for providing full-length viral genome sequences to support researchers globally for the development of vaccines.
  • In August 2019, Eurofins Genomics acquired Blue Heron Biotech, a company specializing in advanced gene synthesis, and expanded its portfolio of oligonucleotides, sequencing, and synthetic genes.
  • In October, GENEWIZ launched NanoString’s GeoMx DSP service for morphological gene and protein expression analysis.

Frequently Asked Questions (FAQ):

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 22)
    1.1 OBJECTIVES OF THE STUDY
    1.2 MARKET DEFINITION
    1.3 MARKET SCOPE
           1.3.1 INCLUSIONS & EXCLUSIONS
           1.3.2 MARKETS COVERED
           1.3.3 YEARS CONSIDERED FOR THE STUDY
    1.4 CURRENCY
    1.5 LIMITATIONS
    1.6 STAKEHOLDERS
    1.7 SUMMARY OF CHANGES

2 RESEARCH METHODOLOGY (Page No. - 26)
    2.1 RESEARCH DATA
           2.1.1 SECONDARY SOURCES
                    2.1.1.1 Key data from secondary sources
           2.1.2 PRIMARY SOURCES
                    2.1.2.1 Key data from primary sources
    2.2 MARKET SIZE ESTIMATION
    2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    2.4 MARKET PLAYER RANKING
    2.5 ASSUMPTIONS FOR THE STUDY
    2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY (Page No. - 35)

4 PREMIUM INSIGHTS (Page No. - 38)
    4.1 BIOINFORMATICS MARKET OVERVIEW
    4.2 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE
    4.3 BIOINFORMATICS MARKET: GEOGRAPHIC MIX
    4.4 BIOINFORMATICS MARKET: REGIONAL MIX

5 MARKET OVERVIEW (Page No. - 41)
    5.1 INTRODUCTION
    5.2 MARKET DYNAMICS
           5.2.1 DRIVERS
                    5.2.1.1 Increasing public-private sector funding for bioinformatics
                    5.2.1.2 Increasing demand for personalized medicine
                    5.2.1.3 Increasing pharmaceutical and biotechnology R&D expenditure
                    5.2.1.4 Decreasing costs of genome sequencing
           5.2.2 RESTRAINTS
                    5.2.2.1 High equipment costs
           5.2.3 OPPORTUNITIES
                    5.2.3.1 Lucrative opportunities in emerging markets
                    5.2.3.2 Adoption of blockchain technology and cloud computing
                    5.2.3.3 Integration of machine learning and AI in healthcare
                    5.2.3.4 Investments by leading IT companies in the development of bioinformatics solutions
           5.2.4 CHALLENGES
                    5.2.4.1 Management of large data volumes
                    5.2.4.2 Lack of interoperability and multiplatform capabilities
                    5.2.4.3 Growing competition from in-house development and publicly available tools
                    5.2.4.4 Shortage of skilled bioinformatics professionals
    5.3 PORTER’S FIVE FORCES ANALYSIS
           5.3.1 THREAT OF NEW ENTRANTS
           5.3.2 BARGAINING POWER OF SUPPLIERS
           5.3.3 BARGAINING POWER OF BUYERS
           5.3.4 THREAT OF SUBSTITUTES
           5.3.5 INTENSITY OF COMPETITIVE RIVALRY
    5.4 VALUE CHAIN ANALYSIS
           5.4.1 RESEARCH AND DEVELOPMENT (R&D)
           5.4.2 RAW MATERIAL
           5.4.3 DISTRIBUTION AND AFTER-SALES SERVICES
    5.5 REGULATORY LANDSCAPE
           5.5.1 GLOBAL ALLIANCE FOR GENOMICS AND HEALTH (GA4GH)
    5.6 CASE STUDIES
    5.7 IMPACT OF COVID-19 ON THE BIOINFORMATICS MARKET
    5.8 ECOSYSTEM/MARKET MAP

6 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE (Page No. - 56)
    6.1 INTRODUCTION
    6.2 KNOWLEDGE MANAGEMENT TOOLS
           6.2.1 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS
                    6.2.1.1 Development of novel standard generalized knowledge management tools to drive market growth
           6.2.2 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS
                    6.2.2.1 Data security and highly reliable information storage system to support specialized knowledge management tools segment
    6.3 BIOINFORMATICS PLATFORMS
           6.3.1 DATA ANALYSIS PLATFORMS
                    6.3.1.1 Increasing need for data analysis during sequencing programs to drive the growth of the segment
           6.3.2 STRUCTURAL & FUNCTIONAL ANALYSIS PLATFORMS
                    6.3.2.1 Growing proteomics research worldwide to drive the adoption of structural & functional analysis platforms
           6.3.3 OTHER BIOINFORMATICS PLATFORMS
                    6.3.3.1 Growing need for DNA and protein sequencing in life science sectors to drive the growth of other bioinformatics platforms
    6.4 BIOINFORMATICS SERVICES
           6.4.1 SEQUENCING SERVICES
                    6.4.1.1 Financial support from the government and private bodies to drive the growth of the segment
           6.4.2 DATA ANALYSIS SERVICES
                    6.4.2.1 Growing adoption of big data analytics in life science research to drive market growth
           6.4.3 DRUG DISCOVERY SERVICES
                    6.4.3.1 Growing technological advancements in pharmacogenomics and increasing collaborations between pharmaceutical companies to drive market growth
           6.4.4 DIFFERENTIAL GENE EXPRESSION ANALYSIS SERVICES
                    6.4.4.1 Increasing R&D for the advancement of solutions and services for differential gene expression studies to drive market growth
           6.4.5 DATABASE AND MANAGEMENT SERVICES
                    6.4.5.1 Growing amount of data generated to increase the need for database and management services
           6.4.6 OTHER BIOINFORMATICS SERVICES

7 BIOINFORMATICS MARKET, BY SECTOR (Page No. - 78)
    7.1 INTRODUCTION
    7.2 MEDICAL BIOTECHNOLOGY
           7.2.1 DRUG DISCOVERY & DEVELOPMENT
                    7.2.1.1 Increasing adoption of bioinformatics services and products for drug designing to drive the segment growth
           7.2.2 CLINICAL DIAGNOSTICS & PERSONALIZED MEDICINE
                    7.2.2.1 Presence of research groups engaged in the development of bioinformatics tools for personalized medicine to propel  market growth
           7.2.3 REPRODUCTIVE HEALTH
                    7.2.3.1 Increasing research and development in the field of reproductive health to bolster market growth in the segment
    7.3 ANIMAL BIOTECHNOLOGY
           7.3.1 RAPID ADVANCES IN THE UNDERSTANDING OF FARM ANIMAL GENOMES TO AID MARKET GROWTH
    7.4 PLANT BIOTECHNOLOGY
           7.4.1 INCREASED USE OF BIOINFORMATICS FOR TIME AND COST-EFFICIENT R&D IN AGRICULTURE TO DRIVE MARKET GROWTH
    7.5 ENVIRONMENTAL BIOTECHNOLOGY
           7.5.1 INCREASING USE OF NGS FOR ENVIRONMENTAL BIOTECHNOLOGY APPLICATIONS TO DRIVE THE MARKET GROWTH
    7.6 FORENSIC BIOTECHNOLOGY
           7.6.1 INCREASING AVAILABILITY OF ADVANCED SOFTWARE FOR INVESTIGATIONAL PURPOSES TO DRIVE THE GROWTH OF  THE SEGMENT
    7.7 OTHER SECTORS

8 BIOINFORMATICS MARKET, BY APPLICATION (Page No. - 95)
    8.1 INTRODUCTION
    8.2 GENOMICS
           8.2.1 DECREASING COST OF NEXT-GENERATION SEQUENCING TO DRIVE THE GENOMICS SEGMENT
    8.3 CHEMOINFORMATICS & DRUG DESIGN
           8.3.1 GROWING USE IN DRUG DESIGNING PROCESS BY PHARMACEUTICAL COMPANIES TO DRIVE CHEMOINFORMATICS SEGMENT
    8.4 PROTEOMICS
           8.4.1 INCREASING APPLICATIONS IN DRUG DISCOVERY TO DRIVE THE PROTEOMICS MARKET
    8.5 TRANSCRIPTOMICS
           8.5.1 TRANSCRIPTOMICS TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD
    8.6 METABOLOMICS
           8.6.1 INCREASING RESEARCH FUNDING TO DRIVE THE  METABOLOMICS SEGMENT
    8.7 OTHER APPLICATIONS
           8.7.1 OTHER APPLICATIONS TO DRIVE RESEARCH IN THE  BIOINFORMATICS MARKET

9 BIOINFORMATICS MARKET, BY REGION (Page No. - 102)
    9.1 INTRODUCTION
    9.2 NORTH AMERICA
           9.2.1 US
                    9.2.1.1 The US dominated the North American market in 2020
           9.2.2 CANADA
                    9.2.2.1 Growth in the genomics field to drive the bioinformatics market in Canada
    9.3 EUROPE
           9.3.1 GERMANY
                    9.3.1.1 Germany is the largest market for bioinformatics products and services in Europe
           9.3.2 UK
                    9.3.2.1 Increasing genomics research to drive market growth in the UK
           9.3.3 FRANCE
                    9.3.3.1 Government initiatives for genomics research to drive market growth in France
           9.3.4 ITALY
                    9.3.4.1 Increasing research in genomics to drive market growth in Italy
           9.3.5 SPAIN
                    9.3.5.1 Presence of several local players in the Spanish bioinformatics market to drive market growth
           9.3.6 ROE
    9.4 ASIA PACIFIC
           9.4.1 CHINA
                    9.4.1.1 Partnerships and collaborations between various industry stakeholders are driving the development of bioinformatics  in China
           9.4.2 JAPAN
                    9.4.2.1 Growing focus of Japanese bioinformatics firms on product launches and collaborations to drive growth
           9.4.3 INDIA
                    9.4.3.1 Preference to outsource pharmaceutical drug discovery to India is a key growth driver
           9.4.4 REST OF ASIA PACIFIC (ROAPAC)
    9.5 REST OF THE WORLD

10 COMPETITIVE LANDSCAPE (Page No. - 153)
     10.1 MARKET OVERVIEW
     10.2 MARKET RANKING ANALYSIS, 2020
     10.3 COMPANY EVALUATION MATRIX: DEFINITIONS AND METHODOLOGY
             10.3.1 INTRODUCTION
             10.3.2 STARS
             10.3.3 PERVASIVE PLAYERS
             10.3.4 EMERGING LEADERS
             10.3.5 PARTICIPANTS
     10.4 COMPETITIVE LEADERSHIP MAPPING: START-UPS/SMES (2020)
             10.4.1 PROGRESSIVE COMPANIES
             10.4.2 STARTING BLOCKS
             10.4.3 RESPONSIVE COMPANIES
             10.4.4 DYNAMIC COMPANIES
     10.5 COMPETITIVE SCENARIO
             10.5.1 PRODUCT & SERVICE LAUNCHES
             10.5.2 EXPANSIONS
             10.5.3 DEALS

11 COMPANY PROFILES (Page No. - 162)
     11.1 KEY PLAYERS
             11.1.1 THERMO FISHER SCIENTIFIC, INC.
                        11.1.1.1 Business overview
                        11.1.1.2 Products & services offered
                        11.1.1.3 Recent developments
                        11.1.1.4 MnM view

             11.1.2 EUROFINS SCIENTIFIC
                        11.1.2.1 Business overview
                        11.1.2.2 Services offered
                        11.1.2.3 Recent developments
                        11.1.2.4 MnM view
                                     11.1.2.4.1 Right to win
                                     11.1.2.4.2 Strategic choices made
                                     11.1.2.4.3 Weaknesses and competitive threats
             11.1.3 ILLUMINA, INC.
                        11.1.3.1 Business overview
                        11.1.3.2 Products & services offered
                        11.1.3.3 Recent developments
                        11.1.3.4 MnM view
                                     11.1.3.4.1 Right to win
                                     11.1.3.4.2 Strategic choices made
                                     11.1.3.4.3 Weaknesses and competitive threats
             11.1.4 PERKIN ELMER, INC.
                        11.1.4.1 Business overview
                        11.1.4.2 Products & services offered
                        11.1.4.3 Recent developments
                        11.1.4.4 MnM view
                                     11.1.4.4.1 Right to win
                                     11.1.4.4.2 Strategic choices made
                                     11.1.4.4.3 Weaknesses and competitive threats
             11.1.5 NEOGENOMICS LABORATORIES
                        11.1.5.1 Business overview
                        11.1.5.2 Products & services offered
                        11.1.5.3 MnM view
                                     11.1.5.3.1 Right to win
                                     11.1.5.3.2 Strategic choices made
                                     11.1.5.3.3 Weaknesses and competitive threats
             11.1.6 QIAGEN N.V.
                        11.1.6.1 Business overview
                        11.1.6.2 Products & services offered
                        11.1.6.3 Recent developments
             11.1.7 SOURCE BIOSCIENCE
                        11.1.7.1 Business overview
                        11.1.7.2 Products & services offered
             11.1.8 AGILENT TECHNOLOGIES, INC.
                        11.1.8.1 BUSINESS OVERVIEW
                        11.1.8.2 Products & services offered
                        11.1.8.3 Recent developments
             11.1.9 DNASTAR
                        11.1.9.1 Business overview
                        11.1.9.2 Products & services offered
                        11.1.9.3 Recent developments
             11.1.10 PSOMAGEN, INC. (FORMERLY KNOWN AS MACROGEN CORP.)
                        11.1.10.1 Business overview
                        11.1.10.2 Products & services offered
                        11.1.10.3 Recent developments
             11.1.11 WATERS CORPORATION
                        11.1.11.1 Business overview
                        11.1.11.2 Products & services offered
                        11.1.11.3 Recent developments
             11.1.12 MICROSYNTH
                        11.1.12.1 Business overview
                        11.1.12.2 Products & services offered
                        11.1.12.3 Recent developments
             11.1.13 GENEWIZ (A BROOKS LIFE SCIENCES COMPANY)
                        11.1.13.1 Business overview
                        11.1.13.2 Products & services offered
                        11.1.13.3 Recent developments
             11.1.14 MEDGENOME LABS LTD.
                        11.1.14.1 Business overview
                        11.1.14.2 Products & services offered
             11.1.15 PARTEK
                        11.1.15.1 Business overview
                        11.1.15.2 Products & services offered
             11.1.16 BEIJING GENOMICS INSTITUTE (BGI)
                        11.1.16.1 Business overview
                        11.1.16.2 Products & services offered
                        11.1.16.3 Recent developments
             11.1.17 BIOMAX INFORMATICS AG
                        11.1.17.1 Business overview
                        11.1.17.2 Products & services offered
                        11.1.17.3 Recent developments
     11.2 OTHER PLAYERS
             11.2.1 SOPHIA GENETICS
             11.2.2 FIOS GENOMICS
             11.2.3 GENUITY SCIENCE (FORMERLY KNOWN AS WUXI NEXTCODE)
             11.2.4 PETDX
             11.2.5 JADBIO
             11.2.6 BIOSYSTEMS IMMUNOLAB PLC.
             11.2.7 ASTALAKE BIOSYSTEMS
             11.2.8 NUCLEOME INFORMATICS PVT. LTD.

12 APPENDIX (Page No. - 213)
     12.1 DISCUSSION GUIDE
     12.2 KNOWLEDGE STORE: MARKETSANDMARKETS’  SUBSCRIPTION PORTAL
     12.3 AVAILABLE CUSTOMIZATIONS
     12.4 RELATED REPORTS
     12.5 AUTHOR DETAILS


LIST OF TABLES (221 Tables)

TABLE 1 PUBLIC-PRIVATE SECTOR FUNDING FOR BIOINFORMATICS AND RELATED FIELDS
TABLE 2 R&D INVESTMENTS BY PHARMACEUTICAL AND BIOTECHNOLOGY COMPANIES IN THE ASIA PACIFIC REGION
TABLE 3 BIOINFORMATICS MARKET: ECOSYSTEM
TABLE 4 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 5 KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 6 KNOWLEDGE MANAGEMENT TOOLS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 7 NORTH AMERICA: KNOWLEDGE MANAGEMENT TOOLS MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 8 EUROPE: KNOWLEDGE MANAGEMENT TOOLS MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 9 APAC: KNOWLEDGE MANAGEMENT TOOLS MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 10 GENERALIZED KNOWLEDGE MANAGEMENT TOOLS MARKET, BY REGION,  2019–2026 (USD MILLION)
TABLE 11 SPECIALIZED KNOWLEDGE MANAGEMENT TOOLS MARKET, BY REGION,  2019–2026 (USD MILLION)
TABLE 12 BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 13 BIOINFORMATICS PLATFORMS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 14 NORTH AMERICA: BIOINFORMATICS PLATFORMS MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 15 EUROPE: BIOINFORMATICS PLATFORMS MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 16 APAC: BIOINFORMATICS PLATFORMS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 17 DATA ANALYSIS PLATFORMS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 18 STRUCTURAL & FUNCTIONAL ANALYSIS PLATFORMS MARKET, BY REGION,  2019–2026 (USD MILLION)
TABLE 19 OTHER BIOINFORMATICS PLATFORMS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 20 BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 21 BIOINFORMATICS SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 22 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 23 EUROPE: BIOINFORMATICS SERVICES MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 24 APAC: BIOINFORMATICS SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 25 SEQUENCING SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 26 NORTH AMERICA: SEQUENCING SERVICES MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 27 EUROPE: SEQUENCING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 28 APAC: SEQUENCING SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 29 DATA ANALYSIS SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 30 NORTH AMERICA: DATA ANALYSIS SERVICES MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 31 EUROPE: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 32 APAC: DATA ANALYSIS SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 33 DRUG DISCOVERY SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 34 NORTH AMERICA: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 35 EUROPE: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 36 APAC: DRUG DISCOVERY SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 37 DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET, BY REGION,  2019–2026 (USD MILLION)
TABLE 38 NORTH AMERICA: DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 39 EUROPE: DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 40 APAC: DIFFERENTIAL GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 41 DATABASE AND MANAGEMENT SERVICES MARKET, BY REGION,  2019–2026 (USD MILLION)
TABLE 42 NORTH AMERICA: DATABASE AND MANAGEMENT SERVICES MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 43 EUROPE: DATABASE AND MANAGEMENT SERVICES MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 44 APAC: DATABASE AND MANAGEMENT SERVICES MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 45 OTHER BIOINFORMATICS SERVICES MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 46 NORTH AMERICA: OTHER BIOINFORMATICS SERVICES, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 47 EUROPE: OTHER BIOINFORMATICS SERVICES MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 48 APAC: OTHER BIOINFORMATICS SERVICES MARKET, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 49 BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION)
TABLE 50 BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY SECTOR,  2019–2026 (USD MILLION)
TABLE 51 BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY REGION,  2019–2026 (USD MILLION)
TABLE 52 NORTH AMERICA: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 53 EUROPE: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 54 APAC: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 55 BIOINFORMATICS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION,  2019–2026 (USD MILLION)
TABLE 56 BIOINFORMATICS MARKET FOR CLINICAL DIAGNOSTICS & PERSONALIZED MEDICINE,  BY REGION, 2019–2026 (USD MILLION)
TABLE 57 BIOINFORMATICS MARKET FOR REPRODUCTIVE HEALTH, BY REGION,  2019–2026 (USD MILLION)
TABLE 58 BIOINFORMATICS MARKET FOR ANIMAL BIOTECHNOLOGY, BY REGION,  2019–2026 (USD MILLION)
TABLE 59 NORTH AMERICA: BIOINFORMATICS MARKET FOR ANIMAL BIOTECHNOLOGY, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 60 EUROPE: BIOINFORMATICS MARKET FOR ANIMAL BIOTECHNOLOGY, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 61 APAC: BIOINFORMATICS MARKET FOR ANIMAL BIOTECHNOLOGY, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 62 BIOINFORMATICS MARKET FOR PLANT BIOTECHNOLOGY, BY REGION,  2019–2026 (USD MILLION)
TABLE 63 NORTH AMERICA: BIOINFORMATICS MARKET FOR PLANT BIOTECHNOLOGY, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 64 EUROPE: BIOINFORMATICS MARKET FOR PLANT BIOTECHNOLOGY, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 65 APAC: BIOINFORMATICS MARKET FOR PLANT BIOTECHNOLOGY, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 66 BIOINFORMATICS MARKET FOR ENVIRONMENTAL BIOTECHNOLOGY, BY REGION,  2019–2026 (USD MILLION)
TABLE 67 NORTH AMERICA: BIOINFORMATICS MARKET FOR ENVIRONMENTAL BIOTECHNOLOGY,  BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 68 EUROPE: BIOINFORMATICS MARKET FOR ENVIRONMENTAL BIOTECHNOLOGY, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 69 APAC: BIOINFORMATICS MARKET FOR ENVIRONMENTAL BIOTECHNOLOGY,  BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 70 BIOINFORMATICS MARKET FOR FORENSIC BIOTECHNOLOGY, BY REGION,  2019–2026 (USD MILLION)
TABLE 71 NORTH AMERICA: BIOINFORMATICS MARKET FOR FORENSIC BIOTECHNOLOGY, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 72 EUROPE: BIOINFORMATICS MARKET FOR FORENSIC BIOTECHNOLOGY,  BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 73 APAC: BIOINFORMATICS MARKET FOR FORENSIC BIOTECHNOLOGY, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 74 BIOINFORMATICS MARKET FOR OTHER SECTORS, BY REGION, 2019–2026 (USD MILLION)
TABLE 75 NORTH AMERICA: BIOINFORMATICS MARKET FOR OTHER SECTORS, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 76 EUROPE: BIOINFORMATICS MARKET FOR OTHER SECTORS, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 77 APAC: BIOINFORMATICS MARKET FOR OTHER SECTORS, BY COUNTRY,  2019–2026 (USD MILLION)
TABLE 78 BIOINFORMATICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 79 GENOMICS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 80 CHEMOINFORMATICS & DRUG DESIGN MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 81 PROTEOMICS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 82 TRANSCRIPTOMICS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 83 METABOLOMICS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 84 OTHER APPLICATIONS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 85 BIOINFORMATICS MARKET, BY REGION, 2019–2026 (USD MILLION)
TABLE 86 NORTH AMERICA: BIOINFORMATICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 87 NORTH AMERICA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,  2019–2026 (USD MILLION)
TABLE 88 NORTH AMERICA: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET,  BY TYPE, 2019–2026 (USD MILLION)
TABLE 89 NORTH AMERICA: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,  2019–2026 (USD MILLION)
TABLE 90 NORTH AMERICA: BIOINFORMATICS SERVICES MARKET, BY TYPE,  2019–2026 (USD MILLION)
TABLE 91 NORTH AMERICA: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION)
TABLE 92 NORTH AMERICA: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2019–2026 (USD MILLION)
TABLE 93 NORTH AMERICA: BIOINFORMATICS MARKET, BY APPLICATION,  2019–2026 (USD MILLION)
TABLE 94 US: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 95 US: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE,  2019–2026 (USD MILLION)
TABLE 96 US: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 97 US: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 98 US: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION)
TABLE 99 US: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2019–2026 (USD MILLION)
TABLE 100 US: BIOINFORMATICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 101 CANADA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,  2019–2026 (USD MILLION)
TABLE 102 CANADA: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE,  2019–2026 (USD MILLION)
TABLE 103 CANADA: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 104 CANADA: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 105 CANADA: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION)
TABLE 106 CANADA: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2019-2026 (USD MILLION)
TABLE 107 CANADA: BIOINFORMATICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 108 EUROPE: BIOINFORMATICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 109 EUROPE: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,  2019–2026 (USD MILLION)
TABLE 110 EUROPE: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 111 EUROPE: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 112 EUROPE: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 113 EUROPE: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION)
TABLE 114 EUROPE: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2019–2026 (USD MILLION)
TABLE 115 EUROPE: BIOINFORMATICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 116 GERMANY: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,  2019–2026 (USD MILLION)
TABLE 117 GERMANY: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 118 GERMANY: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 119 GERMANY: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 120 GERMANY: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION)
TABLE 121 GERMANY: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2019–2026 (USD MILLION)
TABLE 122 GERMANY: BIOINFORMATICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 123 UK: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 124 UK: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE,  2019–2026 (USD MILLION)
TABLE 125 UK: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 126 UK: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 127 UK: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION)
TABLE 128 UK: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2019–2026 (USD MILLION)
TABLE 129 UK: BIOINFORMATICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 130 FRANCE: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,  2019–2026 (USD MILLION)
TABLE 131 FRANCE: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE,  2019–2026 (USD MILLION)
TABLE 132 FRANCE: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 133 FRANCE: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 134 FRANCE: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION)
TABLE 135 FRANCE: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2019–2026 (USD MILLION)
TABLE 136 FRANCE: BIOINFORMATICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 137 ITALY: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 138 ITALY: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE,  2019–2026 (USD MILLION)
TABLE 139 ITALY: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 140 ITALY: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 141 ITALY: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION)
TABLE 142 ITALY: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2019–2026 (USD MILLION)
TABLE 143 ITALY: BIOINFORMATICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 144 SPAIN: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 145 SPAIN: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE,  2019–2026 (USD MILLION)
TABLE 146 SPAIN: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 147 SPAIN: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 148 SPAIN: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION)
TABLE 149 SPAIN: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2019–2026 (USD MILLION)
TABLE 150 SPAIN: BIOINFORMATICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 151 ROE: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 152 ROE: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE,  2019–2026 (USD MILLION)
TABLE 153 ROE: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 154 ROE: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 155 ROE: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION)
TABLE 156 ROE: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2019–2026 (USD MILLION)
TABLE 157 ROE: BIOINFORMATICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 158 ASIA PACIFIC: BIOINFORMATICS MARKET, BY COUNTRY, 2019–2026 (USD MILLION)
TABLE 159 ASIA PACIFIC: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,  2019–2026 (USD MILLION)
TABLE 160 ASIA PACIFIC: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 161 ASIA PACIFIC: BIOINFORMATICS PLATFORMS MARKET, BY TYPE,  2019–2026 (USD MILLION)
TABLE 162 ASIA PACIFIC: BIOINFORMATICS SERVICES MARKET, BY TYPE,  2019–2026 (USD MILLION)
TABLE 163 ASIA PACIFIC: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION)
TABLE 164 ASIA PACIFIC: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE, 2019–2026 (USD MILLION)
TABLE 165 ASIA PACIFIC: BIOINFORMATICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 166 CHINA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 167 CHINA: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE,  2019–2026 (USD MILLION)
TABLE 168 CHINA: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 169 CHINA: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 170 CHINA: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION)
TABLE 171 CHINA: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2019–2026 (USD MILLION)
TABLE 172 CHINA: BIOINFORMATICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 173 JAPAN: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 174 JAPAN: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE,  2019–2026 (USD MILLION)
TABLE 175 JAPAN: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 176 JAPAN: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 177 JAPAN: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION)
TABLE 178 JAPAN: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2019–2026 (USD MILLION)
TABLE 179 JAPAN: BIOINFORMATICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 180 INDIA: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 181 INDIA: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE,  2019–2026 (USD MILLION)
TABLE 182 INDIA: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 183 INDIA: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 184 INDIA: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION)
TABLE 185 INDIA: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2019–2026 (USD MILLION)
TABLE 186 INDIA: BIOINFORMATICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 187 ROAPAC: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,  2019–2026 (USD MILLION)
TABLE 188 ROAPAC: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE,  2019–2026 (USD MILLION)
TABLE 189 ROAPAC: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 190 ROAPAC: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 191 ROAPAC: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION)
TABLE 192 ROAPAC: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2019–2026 (USD MILLION)
TABLE 193 ROAPAC: BIOINFORMATICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 194 ROW: BIOINFORMATICS MARKET, BY PRODUCT & SERVICE, 2019–2026 (USD MILLION)
TABLE 195 ROW: BIOINFORMATICS KNOWLEDGE MANAGEMENT TOOLS MARKET, BY TYPE,  2019–2026 (USD MILLION)
TABLE 196 ROW: BIOINFORMATICS PLATFORMS MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 197 ROW: BIOINFORMATICS SERVICES MARKET, BY TYPE, 2019–2026 (USD MILLION)
TABLE 198 ROW: BIOINFORMATICS MARKET, BY SECTOR, 2019–2026 (USD MILLION)
TABLE 199 ROW: BIOINFORMATICS MARKET FOR MEDICAL BIOTECHNOLOGY, BY TYPE,  2019–2026 (USD MILLION)
TABLE 200 ROW: BIOINFORMATICS MARKET, BY APPLICATION, 2019–2026 (USD MILLION)
TABLE 201 BIOINFORMATICS MARKET: STRENGTH OF PRODUCT OFFERINGS FOR COMPANY EVALUATION
TABLE 202 BIOINFORMATICS MARKET: PRODUCT & SERVICE LAUNCHES, JANUARY 2017–MAY 2021
TABLE 203 BIOINFORMATICS MARKET: EXPANSIONS, JANUARY 2017–MAY 2021
TABLE 204 BIOINFORMATICS MARKET: DEALS, JANUARY 2017–MAY 2021
TABLE 205 THERMO FISHER SCIENTIFIC, INC.: BUSINESS OVERVIEW
TABLE 206 EUROFINS SCIENTIFIC: BUSINESS OVERVIEW
TABLE 207 ILLUMINA, INC.: BUSINESS OVERVIEW
TABLE 208 PERKIN ELMER, INC.: BUSINESS OVERVIEW (2020)
TABLE 209 NEOGENOMICS LABORATORIES: BUSINESS OVERVIEW
TABLE 210 QIAGEN N.V.: BUSINESS OVERVIEW
TABLE 211 SOURCE BIOSCIENCE: BUSINESS OVERVIEW
TABLE 212 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
TABLE 213 DNASTAR: BUSINESS OVERVIEW
TABLE 214 PSOMAGEN, INC.: BUSINESS OVERVIEW
TABLE 215 WATERS CORPORATION: BUSINESS OVERVIEW
TABLE 216 MICROSYNTH: BUSINESS OVERVIEW
TABLE 217 GENEWIZ: BUSINESS OVERVIEW
TABLE 218 MEDGENOME: BUSINESS OVERVIEW
TABLE 219 PARTEK: BUSINESS OVERVIEW
TABLE 220 BGI: BUSINESS OVERVIEW
TABLE 221 BIOMAX INFORMATICS AG: BUSINESS OVERVIEW


LIST OF FIGURES (32 Figures)

FIGURE 1 RESEARCH DESIGN
FIGURE 2 PRIMARY SOURCES
FIGURE 3 BREAKDOWN OF PRIMARIES: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 BIOINFORMATICS MARKET: REVENUE MAPPING-BASED MARKET ESTIMATION (BOTTOM-UP APPROACH)
FIGURE 5 CAGR PROJECTIONS: BIOINFORMATICS MARKET
FIGURE 6 BIOINFORMATICS MARKET: TOP-DOWN APPROACH
FIGURE 7 DATA TRIANGULATION METHODOLOGY
FIGURE 8 BIOINFORMATICS MARKET, BY PRODUCT & SERVICE,  2020 VS. 2026 (USD MILLION)
FIGURE 9 BIOINFORMATICS MARKET, BY SECTOR, 2020 VS. 2026 (USD MILLION)
FIGURE 10 BIOINFORMATICS MARKET, BY APPLICATION, 2020 VS. 2026 (USD MILLION)
FIGURE 11 GROWING APPLICATIONS OF BIOINFORMATICS IS A KEY FACTOR EXPECTED TO DRIVE THE MARKET GROWTH DURING THE FORECAST PERIOD
FIGURE 12 KNOWLEDGE MANAGEMENT TOOLS SEGMENT TO DOMINATE THE BIOINFORMATICS MARKET BY 2026
FIGURE 13 INDIA TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
FIGURE 14 NORTH AMERICA DOMINATED THE MARKET IN 2020
FIGURE 15 BIOINFORMATICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,  AND CHALLENGES
FIGURE 16 VALUE CHAIN ANALYSIS: BIOINFORMATICS MARKET
FIGURE 17 NORTH AMERICA: BIOINFORMATICS MARKET SNAPSHOT (2020)
FIGURE 18 EUROPE: BIOINFORMATICS MARKET SNAPSHOT (2020)
FIGURE 19 ASIA PACIFIC: BIOINFORMATICS MARKET SNAPSHOT (2020)
FIGURE 20 KEY PLAYERS ADOPTED ORGANIC AND INORGANIC GROWTH STRATEGIES BETWEEN 2018 AND 2021
FIGURE 21 RANK OF COMPANIES IN THE GLOBAL BIOINFORMATICS MARKET, 2020
FIGURE 22 BIOINFORMATICS MARKET: GLOBAL COMPETITIVE LEADERSHIP MAPPING, 2020
FIGURE 23 BIOINFORMATICS MARKET: COMPETITIVE LEADERSHIP MAPPING FOR START-UPS/SMES, 2020
FIGURE 24 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2020)
FIGURE 25 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2020)
FIGURE 26 ILLUMINA, INC.: COMPANY SNAPSHOT (2020)
FIGURE 27 PERKINELMER, INC.: COMPANY SNAPSHOT (2020)
FIGURE 28 NEOGENOMICS LABORATORIES: COMPANY SNAPSHOT (2020)
FIGURE 29 QIAGEN N.V.: COMPANY SNAPSHOT (2020)
FIGURE 30 SOURCE BIOSCIENCE: COMPANY SNAPSHOT (2020)
FIGURE 31 AGILENT TECHNOLOGIES, INC.: COMPANY SNAPSHOT (2020)
FIGURE 32 WATERS CORPORATION: COMPANY SNAPSHOT (2020)

This study involved four major activities in estimating the size of the bioinformatics market. Exhaustive secondary research was done to collect information on the market, peer market, and parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across value chains through primary research. The bottom-up approach was employed to estimate the overall market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and sub-segments.

Secondary Research

This research study involved the use of widespread secondary sources, directories, databases (such as Bloomberg Business, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for this extensive, technical, market-oriented, and commercial study of the bioinformatics market. It was also used to obtain important information about the key players alongside market classification and segmentation according to industry trends to the bottom-most level and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the bioinformatics market. It was also used to obtain important information about key market players, market classification and segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report.
The primary sources from the supply side include CEOs, VPs, managing directors, marketing and sales heads/directors, marketing managers, regional/area sales managers, and bioinformatics scientists. Primary sources from the demand side include vice presidents, C-level executives, product managers, department heads, research scientists, research heads, and hospital directors. Other primary respondents include industry experts such as consultants, government, and officials/regulatory authorities.

Bioinformatics Market Size, and Share

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

Both top-down and bottom-up approaches were used to estimate and validate the total size of the bioinformatics market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

  • The key players in the industry and markets have been identified through extensive secondary research
  • The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes
  • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Data Triangulation

After arriving at the market size, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The following figure shows the market validation, source structure, and data triangulation methodology implemented in this report’s market engineering process.

Report Objectives

  • To define, describe, and forecast the bioinformatics market based on products & services, application, sector, and region
  • To provide detailed information regarding the major factors influencing the growth of this market (such as drivers, restraints, opportunities, and challenges)
  • To analyze the micromarkets with respect to individual growth trends, prospects, and contributions to the overall bioinformatics market
  • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast the size of the market segments with respect to four main regions, namely,
    North America, Europe, Asia Pacific and Rest of the World.
  • To profile the key players and analyze their market shares and core competencies
  • To track and analyze competitive developments such as product/service launches & approvals, partnerships, agreements, collaborations, joint ventures, expansions, and acquisitions in the overall bioinformatics market
  • To benchmark players within the market using the proprietary “Competitive Leadership Mapping” framework, which analyzes market players on various parameters within the broad categories of business and product/service strategy

Available Customizations

MarketsandMarkets offers the following customizations for this market report:

  • Additional country-level analysis of bioinformatics market
  • Profiling of additional market players (up to 3)
COVID-19

Get in-depth analysis of the COVID-19 impact on the Bioinformatics Market

Benchmarking the rapid strategy shifts of the Top 100 companies in the Bioinformatics Market

Request For Special Pricing
Report Code
HIT 7543
Published ON
Sep, 2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Bioinformatics Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
CUSTOMIZED WORKSHOP REQUEST
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2021 MarketsandMarkets Research Private Ltd. All rights reserved